Edmond De Rothschild Holding S.A. Vertex Pharmaceuticals Inc Transaction History

Edmond De Rothschild Holding S.A.

$6.04 Billion
Q3 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 1,292 shares of VRTX stock, worth $528,117. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,292

Previous 1,252 3.19%

Holding current value

$528,117

Previous $586,000 2.39%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $18,400 - $20,231	40 Added 3.19%	1,292 $600,000
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $79,347 - $98,077	-202 Reduced 13.89%	1,252 $586,000
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $52,592 - $57,544	-129 Reduced 8.15%	1,454 $607,000
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $41,503 - $49,692	-121 Reduced 7.1%	1,583 $644,000
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $49,712 - $53,281	-147 Reduced 7.94%	1,704 $592,000
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $9,432 - $10,557	-30 Reduced 1.59%	1,851 $651,000
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $1.32 Million - $1.5 Million	-4,646 Reduced 71.18%	1,881 $592,000
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $88,014 - $99,015	308 Added 4.95%	6,527 $1.88 Million
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $1.88 Million - $2.1 Million	-6,867 Reduced 52.48%	6,219 $1.8 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $1.09 Million - $1.36 Million	-4,643 Reduced 26.19%	13,086 $3.69 Million
Q1 2022 May 10, 2022	SELL	$221.42 - $260.97 $511,480 - $602,840	-2,310 Reduced 11.53%	17,729 $4.63 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $1 Million - $1.27 Million	-5,677 Reduced 22.08%	20,039 $4.4 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $373,844 - $418,362	-2,061 Reduced 7.42%	25,716 $4.67 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $94,869 - $111,876	506 Added 1.86%	27,777 $5.6 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $402,239 - $468,865	1,943 Added 7.67%	27,271 $5.86 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $3.15 Million - $4.2 Million	15,211 Added 150.35%	25,328 $5.99 Million
Q2 2020 Aug 07, 2020	BUY	$225.48 - $295.8 $2.23 Million - $2.93 Million	9,903 Added 4627.57%	10,117 $2.94 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $1.76 Million - $2.05 Million	-11,600 Reduced 98.19%	214 $35,000
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $1.94 Million - $2.2 Million	-14,150 Reduced 54.5%	11,814 $1.77 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $3.85 Million - $4.21 Million	25,964	25,964 $3.95 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Account

Edmond De Rothschild Holding S.A. Vertex Pharmaceuticals Inc Transaction History